Transcription factor-based cellular reprogramming has opened the way to converting somatic cells to a pluripotent state, but has faced limitations resulting from the requirement for transcription factors and the relative inefficiency of the process. We show here that expression of the miR302/367 cluster rapidly and efficiently reprograms mouse and human somatic cells to an iPSC state without a requirement for exogenous transcription factors. This miRNAbased reprogramming approach is two orders of magnitude more efficient than standard Oct4/Sox2/ Klf4/Myc-mediated methods. Mouse and human miR302/367 iPSCs display similar characteristics to Oct4/Sox2/Klf4/Myc-iPSCs, including pluripotency marker expression, teratoma formation, and, for mouse cells, chimera contribution and germline contribution. We found that miR367 expression is required for miR302/367-mediated reprogramming and activates Oct4 gene expression, and that suppression of Hdac2 is also required. Thus, our data show that miRNA and Hdac-mediated pathways can cooperate in a powerful way to reprogram somatic cells to pluripotency.
INTRODUCTION
The transformation of differentiated cells to induced pluripotent stem cells (iPSCs) has revolutionized stem cell biology by providing a more tractable source of pluripotent cells for regenerative therapy. Although powerful, there are currently several limitations to iPSC generation, including the rather low efficiency of the process (0.2%-1.0%) and the necessity of forced expression of at least one pluripotent stem cell transcription factor, including Oct4, Nanog, Sox2, Klf4, and/or Myc. These limitations hamper the use of iPSC technology in high throughput formats such as generation of human iPSC clones from large patient populations.
The current standard strategy for iPSC generation relies upon ectopic expression of Oct4, Sox2, Klf4, and Myc (OSKM) (Takahashi and Yamanaka, 2006) . Although there are several alternatives to some of these factors, including the use of other transcription factors, signaling factors, and pharmacological molecules, at least one pluripotent stem cell transcription factor-usually Oct4-is required for efficient iPSC reprogramming (Huangfu et al., 2008a (Huangfu et al., , 2008b Judson et al., 2009; Melton et al., 2010; Yoshida et al., 2009) . Recently, several microRNAs (miRNAs) have been shown to enhance iPSC reprogramming when expressed along with combinations of the OSKM factors (Judson et al., 2009 ). These miRNAs belong to families of miRNAs that are expressed preferentially in embryonic stem cells and are thought to help maintain the ESC phenotype Wang et al., 2007 Wang et al., , 2008 Wang and Blelloch, 2009; ) . How these miRNAs enhance iPSC reprogramming is unclear but may have to do with their ability to regulate the cell cycle (Judson et al., 2009) .
Of the miRNAs expressed at high levels in ESCs and iPSCs, the miR302/367 cluster has been shown to be a direct target of Oct4 and Sox2 (Card et al., 2008) , two of the critical factors required for iPSC reprogramming. Levels of miR302/367 correlate with Oct4 transcripts in ESCs and early embryonic development, indicating an important role in ESC homeostasis and maintenance of pluripotency (Card et al., 2008) . Despite their ability to enhance iPSC reprogramming in the presence of several of the OSKM factors (Judson et al., 2009) , the ability of these miRNAs to directly reprogram somatic cells to an iPSC phenotype is unclear. We show that expression of the miR302/367 cluster can directly reprogram mouse and human somatic cells to a pluripotent stem cell state in the absence of any of the previously described pluripotent stem cell transcription factors. Reprogramming by miR302/367 is up to two orders of magnitude more efficient than that with the OSKM factors. We also show that valproic acid (VPA) is required for reprogramming mouse fibroblasts by specifically degrading Hdac2 protein, a finding that is supported by the efficient reprogramming of Hdac2 À/À fibroblasts in the absence of VPA. Thus, the expression of miR302/367 along with Hdac2 suppression allows for highly efficient iPSC reprogramming without the expression of the known reprogramming factors.
RESULTS

miR302/367 Reprograms Fibroblasts to an iPSC Phenotype
Previous studies have shown that the miR302/367 cluster comprises five miRNAs, four of which-miR302a/b/c/d-have identical seed sequences (Card et al., 2008 ; Figure 1A ). The miR302/367 cluster is located in intron 8 of the Larp7 gene on chromosome 3 and is transcribed as a single polycistronic primary transcript (Card et al., 2008) . The sequences of the miR302/367 miRNAs are highly conserved across species (Card et al., 2008; Rosa et al., 2009) . To determine whether expression of miR302/367 could reprogram somatic cells, we generated a lentiviral vector, which expressed the 690 bp region encoding the mouse miR302/367 sequences, and used it to transfect mouse embryonic fibroblasts (MEFs) derived from the Oct4-GFP mouse line (Lengner et al., 2007 ; Figure 1B) . We included the Hdac inhibitor VPA in these experiments, as this has been shown to enhance iPSC reprogramming (Huangfu et al., 2008a) . Surprisingly, we observed clones derived from miR302/367-transduced MEFs within 6 to 8 days after the start of a viral infection that had already assumed an ESC-like morphology ( Figures 1C and 3A) . Most of these clones were Oct4-GFP positive and alkaline-phosphatase positive ( Figures  1C and 1D ). These clones also expressed Nanog, Sox2, and SSEA1 ( Figure 1E ). In comparison, parallel expression of OSKM-expressing viruses in addition to VPA did not result in any visible clones until at least 8-10 days after starting viral transduction ( Figure 3 and data not shown). Use of a polycistronic virus did not alter the timing or overall number of colonies generated by OSKM expression (data not shown and Sommer et al., 2009 genome (see Figure S1 available online). miR302/367 iPSC clones that have been passaged serially maintain their ESClike morphology and Q-PCR shows that they exhibit identical expression of pluripotent genes as mouse ESCs ( Figure 2C and data not shown). Moreover, the miR302/367 lentivirus is silenced at later passages ( Figure S2 ). These results suggest that expression of miR302/367 in addition to VPA was able to reprogram mouse MEFs to an iPSC state without expression of other previously described pluripotent factors. (Huangfu et al., 2008a) . Using miR302/367, we consistently observed Oct4-GFP-positive clones 7 days after starting viral transduction, which is sooner than cells transduced in parallel with the OSKM factors ( Figure 3A) . By counting the number of clones with ES-like morphology at 8 and 10 days after starting viral transduction, we show that expression of miR302/367 produces two orders of magnitude more iPSC clones than when the OSKM factors are used ( Figure 3B ). At day 10, 79.8% of miR302/367 iPSC clones exhibited robust expression of Oct4-GFP, which is greater than clones expressing the OSKM factors, of which only approximately 50% express Oct4-GFP ( Figure 3C ). To better quantify this increase in iPSC reprogramming efficiency, we performed quantitative real-time PCR (Q-PCR) for pluripotent marker genes during the first 8 days of the reprogramming process on primary induction plates. The experiment used the same number of starting MEFs and viral titer for infection. These data indicate that while cells transduced with the OSKM factors expressed only very low levels of pluripotent marker genes during this time period, miR302/367-transduced cells expressed all of the genes examined at robust levels by day 8 ( Figure 3D ). The numbers of clones were such that after 8-10 days, the plates containing the miR302/367 iPSC clones became overcrowded, resulting in decreased cell viability unless they were isolated and expanded. We also assessed the efficiency of reprogramming by miR302/367 using fluorescence-activated cell sorting (FACS) for expression of GFP from the Oct4 locus in Oct4-GFP MEFs (Lengner et al., 2007) . OSKM-reprogrammed MEFs do show Oct4-GFP expression at both 6 and 8 days of the reprogramming process, with up to 17% of cells expressing GFP by day 8, which is in the same range as previously reported ( Figure 3E ; Huangfu et al., 2008a) . However, miR302/367 is able to activate Oct4-GFP expression in up to 80% of MEFs after 8 days of reprogramming ( Figure 3E ). These data support the conclusion that miR302/367 is able to reprogram fibroblasts to a pluripotent state up to two orders of magnitude more efficiently than OSKM factors. miR302/367 iPSCs Can Generate Derivatives of Mesoderm, Endoderm, and Ectoderm in Teratomas; Generate Adult Chimeras; and Contribute to the Mouse Germline To more fully characterize the pluripotent characteristics of miR302/367 iPSCs, we generated teratomas in immunedeficient mice with multiple miR302/367 iPSC clones. miR302/ 367 iPSC-derived teratomas formed readily and exhibited tissues representing all three germ layers, as noted by structures resembling muscle fibers, keratinized epidermal cells, and luminal structures lined with gut-like epithelium ( Figure 4A ). Supporting these morphological findings, neural epithelial-like structures were positive for bIII-tubulin expression, muscle-like structures were positive for myosin heavy-chain expression, and gut-like epithelium was positive for E-cadherin expression ( Figure 4B ). A more stringent assay for pluripotency is determining whether miR302/367 iPSCs can generate tissues within the developing embryo using chimeric embryo analysis. Therefore, we generated miR302/367 iPSC clones from MEFs made from the Rosa26lacZ mouse line which expresses b-galactosidase ubiquitously (Friedrich and Soriano, 1991) . Injection of these miR302/367 iPSC clones generated high-percentage chimeras in more than 50% of the injected embryos ( Figure 4C and data not shown). Most of these chimeras exhibited 80%-95% contribution from miR302/367 iPSCs to all tissues examined ( Figure 4C and Figure S3 ).
To test whether miR302/367 iPSCs could contribute to the germline of mice, we injected three different mouse miR302/367 iPSC clones derived from Oct4-GFP MEFs. Mouse gonads were collected at E13.5 and E15.5 and visualized both by whole-mount fluorescence and then fixed and sectioned for immunostaining for GFP expression. All three clones contributed efficiently to germ cells in the gonads of chimeric mice ( Figures 4D-4J ). Moreover, miR302/367 iPSC clones generated from C57BL/6 MEFs can generate high-percentage postnatal chimeras, although germline transmission has not yet been examined ( Figure 4K ). Thus, miR302/367 iPSC clones are pluripotent, are competent to generate all three germ layers, and contribute efficiently to the germline of mice. A summary of mouse clones tested for pluripotency is found in Table S1 .
miR302/367 Can Reprogram Human Fibroblasts to a Pluripotent State More Efficiently Than OSKM Factors
To assess whether miR302/367 can reprogram human fibroblasts, we transduced human foreskin and dermal fibroblasts with the miR302/367 lentivirus. Within 12-14 days, we observed clones with the classic human ESC morphology ( Figure 5A ). Immunostaining of these clones showed they expressed OCT4, SSEA4, TRA-1-60, and TRA-1-81 ( Figures 5B-5E ). Q-PCR using three different miR302/367 hiPSC cell clones shows that they all express pluripotent markers at levels equivalent to the hESC line HUES13 ( Figure 5F ). We reprogrammed the human foreskin fibroblast cell line BJ and performed DNA fingerprinting to show that clones from miR302/367 reprogramming are derived from the original parental BJ line ( Figure S4 ). Moreover, these human clones did not contain any integrants of the OSKM viruses, and the miR302/367 virus was silenced in later passages ( Figures S1 and S2 ). Interestingly, VPA was not required for reprogramming human fibroblasts and its addition Cell Stem Cell miRNA-Mediated Pluripotent Stem Cell Reprogramming did not affect the efficiency of reprogramming (see below and data not shown). Teratomas were generated from seven different miR302/367 hiPSC clones and all exhibited formation of mesoderm, endoderm, and ectoderm ( Figures 5G-5L) . A summary of human clones tested for pluripotency is found in Table S1 . We next assessed whether there was an increase in human reprogramming efficiency similar to what we observed in MEFs. Starting with the same number of human foreskin fibroblasts and OSKM and miR302/367 viral titers, the number of colonies with ES-like morphology formed at 18 and 26 days after starting viral transduction is two orders of magnitude greater for miR302/ 367 than when using OSKM expression ( Figure 5M ). Based on the cell counts, approximately 10% of human fibroblasts used for viral transduction produce iPSC clones ( Figure 5M ). Q-PCR from primary induction plates also reveals a dramatic increase in pluripotent gene expression in miR302/367-expressing versus OSKM-expressing human foreskin fibroblasts ( Figure 5N ). These data indicate that miR302/367 can reprogram human as well as mouse fibroblasts to an iPSC state with greatly increased efficiency.
miR367 Expression is Required for miR302/367 iPSC Reprogramming The miR302/367 cluster contains five different miRNAs, miR302a/b/c/d and miR367. All are expressed from a common promoter located in intron 8 of the Larp7 gene (Card et al., 2008) . miR302a/b/c/d all share a common seed sequence suggesting that they target a similar set of mRNAs and thus may act redundantly ( Figure 1A ). However, miR367 has a different seed sequence and thus may target a different set of mRNAs ( Figure 1A ). Therefore, we tested whether miR367 expression is required for miR302/367 iPSC reprogramming. Using a lentivirus lacking the miR367 sequence, we infected Figure 6C ). Importantly, Oct4 expression is not observed at detectable levels in response to miR302a/b/c/d expression ( Figure 6C, arrow) . Using FACS analysis and Oct4-GFP MEFs, we show that there is no induction of Oct4 gene expression when expressing miR302a/b/c/d without miR367 while miR302/367 expression induces robust Oct4-GFP expression by day 8 ( Figure 6D ). These data show that without miR367 expression, miR302a/b/c/d expression was unable to reprogram mouse MEFs and that this correlated with a lack of induction of Oct4 gene expression. Thus, the coordinated action of the miR302a/b/c/d family along with miR367 is required for iPSC reprogramming.
Low Levels of Hdac2 Permit miR302/367 Reprogramming Recent evidence has pointed to an important role for chromatin remodeling factors in regulating the ESC pluripotent state (Lagarkova et al., 2010; Mali et al., 2010) . Previous data have shown that VPA, a known Hdac inhibitor, enhances OSKM reprogramming, suggesting an important role for Hdac-mediated chromatin remodeling in iPSC reprogramming (Huangfu et al., 2008a) . We initially found that, in the absence of VPA, miR302/ 367 was unable to efficiently reprogram MEFs to iPSCs and of the few clones that did develop, none survived clonal replating ( Figures 7D and 7F and data not shown). Interestingly, VPA was not necessary for reprogramming of human foreskin or dermal fibroblasts ( Figure 5 ). VPA has been reported to specifically degrade Hdac2 protein (Kramer et al., 2003) . Therefore, we assessed whether expression of class I Hdacs was altered by miR302/367 or VPA treatment by performing western blots for Hdac1, -2, and -3 expression during miR302/367-mediated reprogramming. While Hdac1 and Hdac3 expression levels were unchanged in all conditions, VPA caused degradation of Hdac2 protein in MEFs ( Figure 7A ). Expression of miR302/367 did not affect the levels of Hdac1, -2, or -3 in the presence or absence of VPA in MEFs ( Figure 7A ). In contrast, human foreskin fibroblasts expressed much lower levels of Hdac2 protein, and the protein levels of Hdac2 were not affected by VPA in these cells ( Figure 7B ). These data suggest that low levels of Hdac2 may significantly enhance or even be required for miR302/367 reprogramming and that human fibroblasts express much lower levels of Hdac2 than MEFs.
To test whether suppression of Hdac2 is specifically required for efficient reprogramming by miR302/367, we generated Hdac2 À/À MEFs from Hdac2 flox/flox mice using adenoviral-mediated cre excision of Hdac2 and determined whether loss of Hdac2 altered the efficiency of miR302/367 reprogramming of MEFs in the absence of VPA ( Figure S5 ). We found that in Hdac2 À/À MEFs transduced with the miR302/367 virus, Oct4-GFP-positive clones were observed as early as 6 days post-viral infection ( Figure 7C ). Eight days after viral transduction, Hdac2 À/À MEFs had formed significant numbers of iPSC clones in the absence of VPA, whereas wild-type MEFs in the absence of VPA did not generate any viable clones ( Figure 7D ). VPA addition to Hdac2 À/À MEFs did not change the number of iPSC clones obtained ( Figure 7D ). The number of iPSC clones generated and the percentage of clones that were Oct4-GFP positive with miR302/367-transduced wild-type MEFs plus VPA and miR302/367-transduced Hdac2 À/À MEFs lacking VPA were similar ( Figure 7D and 7E). Loss of Hdac2 expression or VPA addition did not affect proliferation rates in MEFs 
DISCUSSION
Current strategies for generating iPSCs rely upon expression of multiple pluripotent stem-cell-associated transcription factors. We show that a single miRNA cluster, miR302/367, can reprogram fibroblasts more efficiently than the standard OSKM method. With ongoing advances in miRNA biology, these findings may lead to a nonviral, nontranscription-factor mediated procedure for generating iPSCs for use not only in basic stem cell biology studies, but also for high throughput generation of human iPSC clones from large patient populations. Previous studies have demonstrated the usefulness of iPSCs not only in the study of basic stem cell biology, but also in the ability to generate patient-specific iPSC clones, which can then be further differentiated into the cell lineage of choice, including hematopoietic, cardiomyocyte, and hepatocyte cell lineages (Moretti et al., 2010a (Moretti et al., , 2010b Raya et al., 2010; Si-Tayeb et al., 2010) . However, at this point the low efficiency of iPSC reprogramming is an impediment to adapting the process to highthroughput approaches. Such approaches would allow for the generation of iPSC clones from large patient populations obtained from genome-wide association studies for use in characterizing the identified genomic differences at the cell biological level. Our finding that reprogramming by miR302/367 is up to two orders of magnitude more efficient than the OSKM factors suggests that this method may prove to be amenable for use in large-scale iPSC generation. Several other reports have demonstrated that using techniques including Sendai viral expression as well as direct transfection of synthesized mRNAs for the OSKM factors can improve the efficiency of iPSC reprogramming (Seki et al., 2010; Warren et al., 2010) . Based on our data, we obtain efficiencies that are greater than either of these techniques, and using human fibroblasts, the percentage of cells that generate iPSC clones approaches 10%. Thus, miR302/367 iPSC reprogramming is more efficient than previously described methods, including transfection of synthetic mRNAs for OSKM factors (Warren et al., 2010) .
The mechanism underlying the increased efficiency of miR302/ 367 iPSC reprogramming is likely to revolve in part around the nature of miRNA biology. First, miRNA expression does not require protein translation and thus leads to a fast response on protein expression based on inhibition of mRNA translation and stability. Second, miRNAs generally target scores or hundreds of mRNAs that coordinate expression of many different proteins, which can rapidly impose a dominant phenotypic change in cell identity. This ability to target many different mRNAs also simultaneously increases the complexity underlying the mechanism of miR302/367 function. miR302/367 collectively targets hundreds of different mRNA targets, including those that regulate chromatin remodeling and cell proliferation based on bioinformatic prediction algorithms (Betel et al., 2008; Grimson et al., 2007; Krek et al., 2005) . Our data indicate that miR367 expression is essential for iPSC reprogramming by the miR302/367 cluster. As miR367 has a different seed sequence, suggesting a different set of mRNA targets, analysis of the combinatorial regulation of miR302a/b/c/d and miR367 targets may provide important information regarding both the pluripotent gene network and also factors whose expression is required to be suppressed for efficient iPSC reprogramming.
Our studies underscore the role of Hdac2 in iPSC reprogramming. The specific degradation of Hdac2 protein by VPA is likely the reason that this small molecule has been found to be more efficacious than other Hdac enzymatic inhibitors in enhancing iPSC reprogramming (Huangfu et al., 2008a) . Several recent studies have demonstrated the importance of other chromatin remodeling processes in iPSC reprogramming (Bhutani et al., 2010; Lagarkova et al., 2010; Mali et al., 2010) . Hdac2 has also been found to be part of an extended regulatory network for pluripotency in ESCs by interacting with both Oct4 and Myc (Kim et al., 2008) . Since iPSC reprogramming involves the resetting of the epigenetic state of a differentiated cell to a pluripotent ''ground state,'' additional studies into the necessity of chromatin remodeling will likely lead to better insight into cell lineage transdifferentiation events. Our finding that human cells, which express much lower levels of Hdac2 protein, do not require VPA for miR302/367-mediated reprogramming suggests that differing levels of Hdac2 may account, at least in part, for the different iPSC reprogramming efficiencies exhibited by different cell lineages. Moreover, Hdac2 expression may decline during development such that adult cells have little Hdac2 protein, resulting in the absence of an affect by VPA. Future studies into whether these correlations exist more broadly in other cell lineages may be beneficial for optimizing reprogramming by other methods including the OSKM factors.
Our studies show that miRNAs can be powerful tools for mediating iPSC reprogramming without the need for pluripotent factors including the OSKM factors. The current focus on developing miRNAs for therapeutic use could lead to a nonviral mediated method of altering miR302/367 expression, which could in turn allow for a rapid miRNA/small molecule approach for iPSC reprogramming.
EXPERIMENTAL PROCEDURES Lentiviral Vector Construction
A mouse genomic DNA fragment comprising miR302/367 or miR302a/b/c/d family of miRNA was amplified by PCR using primers listed in Table S1 . The amplified fragment was cloned into Acc65I and XhoI restriction enzyme sites of pENTR1A entry vector (Invitrogen) and verified by sequencing. The fragment was excised from the entry vector and ligated into BsrGI site of pLOVE destination vector resulting in pLOVE-miR302/367 vector. The pLOVE-miR302a/b/c/d vector was generated in the same fashion, but using a different 3 0 primer that excluded the miR367 sequence.
Cell Culture, Viral Production, and Induction of Pluripotent Stem Cells Mouse fibroblasts were isolated from Oct4-GFP, Rosa26-LacZ, and Hdac2 flox/flox embryos at E13.5 and cultured in fibroblast medium as described (Takahashi et al., 2007) . Hdac2 was excised by infection of Hdac2 flox/flox MEFs with adeno-cre virus. Human dermal fibroblasts were cultured in DMEM/F12, 15% FBS, penicillin/streptomycin, and L-glutamine. Viral particles were generated by transfection of plated 293T cells with pLOVE vectors encoding miR302/367, Oct4, Sox2, Klf4, or N-myc along with pMD.G and psPAX2 vectors as described . Supernatant from the transfected cells were collected every 24 hr for 48 hr and titered. The titered viral suspension was mixed with 0.5 ml of 10 mg/ml polybrene (American Bioanalytical, MA) per milliliter of viral suspension and used to infect fibroblasts. After viral infection, mouse fibroblasts were cultured in mouse ES medium supplemented with or without valproic acid at a final concentration of 2 mM for the indicated length of time. Infected human fibroblasts were cultured in human ES medium as described ( RNA Isolation, Quantitative RT-PCR, and Microarray Experiments Total RNA was isolated using Trizol (Invitrogen). Two micrograms of RNA were used to synthesize cDNA using Superscript First Stand Synthesis Kit (Invitrogen). Real-time PCR was performed using SYBR Green (Applied Biosystems) by 7900HT Fast Real-Time PCR System (Applied Biosystems). Real-time primer sequences are listed in Table S1 . For microarray experiments, the Affymetrix Mouse Gene 1.0 ST arrays were used. Microarray data were analyzed using Robust Multichip Analysis (RMA) and Principal Component Analysis (PCA) and the Partek Genomics Suite v6.5.
Teratoma Formation and DNA Fingerprinting Analysis miR302/367 iPSCs were passaged twice on 0.1% gelatin-coated plates for an hour to remove feeders. A total of 5 3 10 5 cells were mixed with Matrigel and injected into each flank of NOD-SCID mice. Tumors were harvested at 4 weeks postinjection, fixed in 4% paraformaldehyde, and embedded in paraffin. Sectioned tumors were stained for hematoxylin and eosin. For immunofluorescence staining, the primary antibodies were bIII-tubulin (Abcam), , and E-cadherin (Cell Signaling). Genomic DNA from human miR302/367 iPSC clones was used for DNA fingerprinting analysis (Cell Line Genetics, LLC, Madison, WI.).
Generation of Mouse Chimeras with miR302/367 iPSC Clones miR302/367 iPSCs were generated using Rosa26-LacZ mouse embryonic fibroblasts (Friedrich and Soriano, 1991) . The cells were passaged twice on See also Figures S5 and S6 .
0.1% gelatin-coated plates for an hour to remove feeders and injected into E3.5 C57BL/6 blastocysts. Embryos were harvested at E9.5 and E13.5 and stained for LacZ activity using previously described methods (Shu et al., 2002) . For germline contribution experiments, miR302/367 iPSC clones C6, C7, and C10, which were generated from Oct4-GFP MEFs, were used for blastocyst injections. Gonads were harvested from E13.5 and E15.5 embryos, visualized by fluorescence microscopy, and then fixed and sectioned for GFP immunostaining. Embryos and tissues were embedded in paraffin and sectioned as described (Cohen et al., 2009; Shu et al., 2002) . All three clones contributed to the germline.
Western Blots
Total cell lysates were prepared for western blotting as previously described (Trivedi et al., 2008) . Equal amounts of protein were resolved by SDS-PAGE and transferred to polyvinylidenedifluoride membranes. Membranes were incubated with Hdac1 antibody (1:1000 dilution, Cell Signaling), Hdac2 antibody (1:1000 dilution, Invitrogen), or Hdac3 antibody (1:1000 dilution, Sigma). Primary antibody binding was visualized by HRP-conjugated secondary antibody and detected by enhanced chemiluminescence (LumiGlo, Cell Signaling). For loading control, membranes were reprobed with primary antibody against GAPDH (1:2500 dilution, Abcam).
Proliferation Assays
Proliferation assays for MEFs were performed using the CellTiter 96 Aqueous One Solution Cell Proliferation kit (Promega, Inc.). Twenty microliters of CellTiter Reagent, which functions by being incorporated by viable cells into a colorimetric product that can be measured at 490 nm, was added to 100 ml of culture medium, incubated at 37 C, and absorbance was measured at 490 nm at 1.5 hr, 2.5 hr, and 4.5 hr.
Generation of Conditional Hdac2 flox/flox Mice
The Hdac2 flox/flox allele was generated by flanking exon 2 with loxP recombination sites using the targeting vector depicted in Figure S5A . Upon cre-mediated recombination, exon 2 is deleted and the resulting mRNA is out of frame with multiple early stop codons producing premature termination and loss of Hdac2 protein. This construct was electroporated into R1 ESCs; correctly targeted ES clones were identified using Southern blot analysis ( Figure S5B ) and used to generate high percentage chimeras and germline transmission of the Hdac2 flox/+ allele. Ubiquitous CMV-Cre transgenic mice were used to delete Hdac2 and to demonstrate the resulting loss of Hdac2 protein by western blot analysis ( Figure S4C ). Hdac2 flox/flox mice were crossed with Oct4-GFP knock-in mice (Lengner et al., 2007) 
